The AI engine for the biotech close
Metis Flow puts an AI engine on your close. It handles the busy work so your team spends time on the decisions that matter.
An engine, not a memory
Intelligence built in
It understands your close and starts on its own, the moment the work appears.
It does the manual part
The busy work of the close gets handled, so it stays off your team's plate.
You keep the judgment
It brings you the information. You keep the final say.
The close doesn't have to be brutal
Buy back your time. Most finance teams do not need another ERP implementation. They need an engine.
One product. Two engines
The accrual engine
Designed to automate the accruals your team rebuilds manually on Excel, drawn from your AP inbox, POs, non-PO spend, services, emails, and spreadsheets.
The close reviewer
Reviews the whole close and surfaces what looks off, so you can catch it before it reaches anyone else. Senior enough to trust.
Metis Flow handles your non-clinical accruals alongside your existing team and the stack of systems you already run.
A draft entry, ready for review
It proposes the entry. On the calls that need judgment, a person approves before it posts.
Illustrative example, not a client result.
A.I. is made by humans, intended to behave by humans and, ultimately, to impact humans' lives and human society.
Fei-Fei Li, co-founder of the Stanford Institute for Human-Centered AI
How we keep it accountable
You control what it sees
Metis Flow works only from the sources you connect, and you can switch it off at any time. You decide the inputs, and it stays within them.
A human on the judgment calls
Metis Flow proposes, and your team reviews and posts what calls for judgment. Routine recurring entries can flow on their own, so people spend attention where it counts.
Every action, on the record
A full audit trail sits behind each proposed entry, so your controls and audit prep stay exactly where they belong.
Built by a finance leader who has run the close
Metis Flow was built by a finance operator who lived the month-end close, running non-clinical accruals manually at early-stage biotech. It is the system they wished they had.
Experience it on your own close
Book a walkthrough and see what an AI-enabled close looks like on your numbers.
Book a walkthrough